Repare Therapeutics (NASDAQ: RPTX)
$1.65
(2.5%)
$0.04
Price as of August 27, 2025, 4:00 p.m. ET
Repare Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Repare Therapeutics Company Info
Repare Therapeutics, Inc. engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company was founded on September 6, 2016 and is headquartered in Saint-Laurent, Canada.
News & Analysis
Featured Article
Repare (RPTX) Q2 Loss Narrows 52%
Motley Fool Markets Team | Aug 8, 2025
Featured Article
Wall Street Thinks This Cathie Wood Stock Could Jump by 187%
This small-cap biotech stock holds enormous growth potential.
George Budwell | Aug 16, 2023
Why Repare Therapeutics Stock Is Skyrocketing Today
Keith Speights | Jun 2, 2022
The company just announced a major collaboration with multinational pharmaceutical giant Roche.
2 Biotech Stocks ARK Invest Bought in June
Cory Renauer | Jun 7, 2021
Should you follow Cathie Wood's latest genomic revolution investments?
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.